Moore Capital Management’s Charles River Laboratories CRL Stock Holding History

Moore Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$883K	Sell	3,892 -39,342	-91%	-$7.01M	0.01%	499
2026 Q1	$7.46M	Buy	43,234 +32,331	+297%	+$5.99M	0.15%	116
2025 Q4	$2.17M	Sell	10,903 -38,022	-78%	-$6.9M	0.03%	362
2025 Q3	$7.65M	Buy	48,925 +22,116	+82%	+$3.51M	0.11%	178
2025 Q2	$4.07M	Sell	26,809 -15,116	-36%	-$2.02M	0.05%	246
2025 Q1	$6.31M	Buy	41,925 +27,438	+189%	+$4.6M	0.13%	159
2024 Q4	$2.67M	Buy	+14,487	New	+$2.79M	0.03%	298
2015 Q3	–	Sell	-65,000	Closed	-$4.57M	–	309
2015 Q2	$4.57M	Buy	+65,000	New	+$4.81M	0.1%	216

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Moore Capital Management's CRL Position: Q2 2026 in Review

Moore Capital Management reduced its Charles River Laboratories (CRL) stake by 91% in Q2 2026, selling an estimated $7.01M and leaving 3,892 shares worth $883K. The position accounts for 0.01% of the portfolio, ranked #499.

Moore Capital Management first reported a position in CRL in Q2 2015 and has held it in 8 quarters since. The position peaked at $7.65M in Q3 2025. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Moore Capital Management held 3,892 shares of Charles River Laboratories worth $883K as of Q2 2026.
Moore Capital Management sold 39,342 Charles River Laboratories shares in Q2 2026, an estimated $7.01M.
Charles River Laboratories made up 0.01% of Moore Capital Management's portfolio in Q2 2026, its #499 holding.
Moore Capital Management first reported a position in Charles River Laboratories in Q2 2015 and has held it in 8 quarters since.
Moore Capital Management's Charles River Laboratories position peaked at $7.65M in Q3 2025.
569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.